This cross-sectional investigation studied the association between substance use and patients' desire for autonomy in medical decision making (MDM) in two trauma settings. A total of 102 patients (age 42.7 ± 17.4 years, 70.6% male) admitted to an orthopaedic service in Warsaw, Poland, and 1009 injured patients (age 34.6 ± 12.8 years, 62.3% male) treated in an emergency department in Berlin, Germany, were enrolled. Patients' desire for autonomy in MDM was evaluated with the Decision Making Preference Scale of the Autonomy Preference Index. Substance use (hazardous alcohol consumption and/or tobacco use) and educational level were measured. Linear regression techniques were used to determine the association between substance use and desire for autonomy in MDM. Substance use was found to be independently associated with a reduced desire by the patient for autonomy in medical decision making. No differences in patients' desire for autonomy were observed between the study sites. Empowerment strategies that encourage smokers or patients with hazardous alcohol consumption to participate in MDM may increase the effectiveness of health promotion and injury prevention efforts in this population.
Introduction
A growing body of research has shown that when patients play a significant role in deciding how they are going to manage their health condition they are more likely to adhere to the treatment, resulting in improved outcomes. 1 -3 Patient involvement in medical decision making (MDM) not only leads to improved patient satisfaction and improved adherence with treatment regimens in chronic diseases such as diabetes, hypertension, or depression, 3 but is also associated with greater compliance with stopping smoking and other behavioural health recommendations. 4 Thus, MDM processes are important determinants of treatment success and this has led to an increased interest in understanding how patients make decisions concerning their health care. 5 A patient's autonomy varies in the different forms of MDM: in physician-based MDM, 6 the physician makes diagnostic and treatment decisions unilaterally and the patient's involvement is limited to consenting to the physician's choice. 7 In shared MDM, the patient is more autonomic and plays a collaborative decision making role. 8, 9 In informed MDM, a patient makes a completely autonomous decision after being told about the available treatment options by their physicians. 7 An impaired desire for autonomy in MDM may affect the patient's compliance with recommended therapies, including interventions designed to reduce the risk of injury recurrence. We posed the hypothesis that trauma patients who use alcohol in a hazardous manner or who use other harmful substances, such as tobacco, show less desire for autonomy in MDM. This hypothesis was tested by comparing the desire for autonomy in MDM in patients with and without a positive screen for substance use in two trauma populations in two cultural settings.
Patients and methods

STUDY DESIGN AND PATIENT ENROLMENT
The study was approved by the Institutional Review Committees of Warsaw University, Poland and Charité-Universitätsmedizin in Berlin, Germany. Written informed consent for study participation was obtained from all patients.
The Patients were considered eligible if they were treated for an acute injury in the emergency department of Charité-Universitätsmedizin. Patients were excluded at both sites if they were unable to provide informed consent, did not have a fixed address, were under arrest, or spoke a language other than Polish (in Warsaw) or German (in Berlin).
PATIENT ASSESSMENT
Patients were screened for hazardous alcohol consumption with the Alcohol Use Disorder Identification Test (AUDIT). A score ≥ 8 points was considered a positive screen. 11 Patients were also asked about current tobacco use at the time of study entry and were classified as a 'substance user' if they had a positive screen in the AUDIT and/or were a current smoker. Demographic data including age, gender and educational level were also recorded. Educational level was converted into a binary variable with 'high school diploma' meaning any formal school education of ≥ 12 years, and 'no high school diploma' meaning ≤ 11 years of school education.
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was assessed using the Decision Making Preference Scale (DMPS) from the Autonomy Preference Index. 12 The DMPS explores a patient's desire for autonomy related to potential involvement in hypothetical medical decision processes using a Likert Scale. Scores range between 6 and 30 points, with higher scores indicating increasing desire for autonomy in MDM. Questionnaires were provided in either Polish or German, as appropriate.
STATISTICAL ANALYSIS
Multiple linear regression with stepwise variable selection was performed to analyse the association between patients' desire for autonomy in MDM and covariates such as age, gender, education, Berlin or Warsaw location, and substance use. A P-value ≤ 0.05 was considered to be statistically significant. When analysing the data from Warsaw and Berlin in one model, the patients were weighted according to the number enrolled at each study site, and interaction terms between the study site and all other covariates were entered into the model. All statistical analyses were performed using Free Software 'R', Version 2. 
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Autonomy in medical decision making factor that was independently associated with a reduced desire for autonomy in MDM was female gender, although this was not statistically significant. The Berlin group consisted of 1073 injured patients, 64 of whom were excluded due to incomplete data. The study population, therefore, comprised 1009 patients with a mean ± SD age of 34.6 ± 12.8 years, 62.3% of whom were male ( Table 1) . Compared with the Warsaw group, patients in the Berlin component of the study were significantly less likely to have an alcohol problem (16.7%, P < 0.01) and were significantly more likely to have a high school diploma (52.8%, P < 0.01). A similar proportion of the patients in the two groups were smokers (46.5%, P > 0.05). The mean ± SD for DMPS scores in the Berlin group was 17.7 ± 4.4 points. In Berlin, substance use (a positive AUDIT and/or current tobacco use) was associated with a significantly reduced desire for autonomy in MDM (P = 0.037).
When analysing the data from Warsaw and Berlin in one model, neither location nor any interactions between the study location and other covariates were associated with level of desire for autonomy in MDM. Preference for autonomy in MDM was negatively associated with age (each additional year: β age = -0.02, P = 0.05), male gender (β gender = -0.91, P < 0.001) and substance use (β substance use = -0.573, P = 0.03). There was a strong positive association between desire for autonomy in MDM and having a high school diploma (β high school diploma = 2.092, P < 0.001).
Discussion
No differences in the desire for autonomy were found between the Warsaw and Berlin trauma patients. Female gender and advanced educational level were independently associated with a greater desire for autonomy in MDM. Additionally, patients with a hazardous alcohol consumption and current smokers had a reduced desire for autonomy in MDM, independent of these factors. This lack of participatory interest in MDM may be a barrier to the successful implementation of health promotion interventions designed to address the risk of re-injury in trauma patients, as well as interventions designed to reduce harmful substance use. 14 It may be difficult to increase motivation to reduce or stop harmful substance use in patients who have a less autonomic attitude towards their health care, as this may cause them to marginalize the effects of their substance use. Interestingly, the factors that were associated with a reduced desire for autonomy in MDM, such as male gender and lower educational level, 12 have also been associated with substance abuse. 15, 16 Patients wishing less autonomy in MDM may also be perceived by their physician as not being sufficiently engaged or motivated in making decisions about their healthcare. 17 This may result in paternalistic, but perfunctory repetition of recommendations, for example to quit smoking, etc., without development of the rapport that leads to successful behavioural change. 18 Health promotion interventions, such as motivational interviewing 19 for alcohol or smoking problems are based, in part, on engaging the patient in making decisions about their health. After exploring the patient's reasons to stop, reduce or continue their harmful behaviour, 20 the clinician offers a choice of options and encourages the patient to choose the option that makes the best sense for him or her, in order positively to influence their health. 19 Methods that encourage autonomy may, therefore, be relevant not only to improving a trauma B Neuner, A Dizner-Golab, LM Gentilello et al.
Autonomy in medical decision making patient's compliance with post-discharge medical and surgical therapies, but also with health-promoting interventions, such as screening and intervention procedures for substance use. In general, improved compliance with recommended therapies and increased satisfaction after MDM are attributed to a better understanding of the patient's desire by the physician. This may lead to more customized or individually appropriate treatment proposals, and to increased knowledge and identification with the final treatment decisions by the patient. 21 Techniques that foster or increase the patient's participation in, and desire for, healthcare autonomy may, therefore, increase the efficacy of screening and intervention programmes.
There are several limitations to this study. This is the first time that the DMPS from the Autonomy Preference Index has been used in a Polish sample and it has not been previously validated in this population. In addition, there was a large discrepancy in the number of patients enrolled at each study site. This was due to different entry criteria; the Warsaw sample consisting entirely of patients admitted to the hospital, whereas the Berlin component primarily consisted of an injured but ambulatory population. Although we adjusted for age, gender, education and other factors, these differences in injury severity may be associated with other patient factors that we are unable to identify. Finally, while inadequate statistical power may be responsible for the lack of statistical significance in the subgroup analysis of the patients from Warsaw, the existence of a type 2 error can only be inferred and will require independent verification by larger studies.
In conclusion, this trans-cultural comparison shows that substance use is independently associated with a reduced desire by the patient for autonomy in medical decision making. Whilst a causal relationship has not been established, further studies are warranted to determine the extent to which these traits are related and whether strategies that promote patients' autonomy increase the effectiveness of interventions designed to address substance abuse.
